Illumina Newswire (Page 3)

Comprehensive Real-Time News Feed for Illumina. (Page 3)

Results 41 - 60 of 766 in Illumina

  1. Big Ideas, Big PictureRead the original story w/Photo

    Nov 14, 2014 | Barron's

    ... also receives recurring revenue via the chemicals and enzymes that need to be replaced with each application. Illumina has recently moved into individual diagnostics, the implications of which could be enormous. "We are at the tip of the iceberg of ...

    Comment?

  2. Stock Market Treads Water; Earnings Drive BitAutoRead the original story w/Photo

    Nov 14, 2014 | Investor's Business Daily

    Stocks struggled for direction for most of the day Friday amid upbeat data on retail sales and consumer sentiment. But the main indexes ultimately ended mildly higher.

    Comment?

  3. Tariff deal could help local tech companiesRead the original story w/Photo

    Nov 11, 2014 | The San Diego Union-Tribune

    ... made high-tech products square off more effectively against offerings from foreign companies. "One local example is Illumina competing with (Beijing Genomics Institute) in China," Topol said. "Taking down the tariffs could help Illumina compete in ...

    Comment?

  4. Big Cap 20 Stuffed With Medical NamesRead the original story w/Photo

    Nov 10, 2014 | Investor's Business Daily

    Nine of the Big Cap 20 names this week are in medical-related fields, revealing that the leadership among these names over the past few years has continued despite October's correction, which whittled more than 10% off the Nasdaq. , which develops drugs that treat blood disorders, is extended from a 179.69 buy point from a cup-with-handle base that began in February.

    Comment?

  5. Investor's Corner: New Series On Spotting Funds' BuysRead the original story w/Photo

    Nov 6, 2014 | Investor's Business Daily

    ... gain. Even when a stock hasa strong rating, investors still need to pay close attention to its chart action. Illumina cleared a double-bottom base the day after the follow-through. Illumina rallied about 8% to an all-time high past a 182.37 buy ...

    Comment?

  6. IQ4I research & Consultancy Published New Report on Next Generation Sequencing (NGS) Global MarketRead the original story

    Nov 5, 2014 | PR Log

    ... institutes are the largest end users in the region but hospitals and clinics segment is expected to grow faster. Illumina Inc (U.S.) is the largest player in the NGS market with a share of XX%, followed by Thermo Fisher Scientific (U.S.) and Roche ...

    Comment?

  7. Why Thermo Fisher Scientific Shares Could Appreciate MateriallyRead the original story w/Photo

    Nov 5, 2014 | Seeking Alpha

    ... and as genetic testing becomes more ubiquitous, we believe this sector is poised to explode exponentially. While Illumina (NASDAQ: ILMN ) currently leads in marketshare of DNA sequencing, we think this space can have multiple winners. Just as Apple ...

    Comment?

  8. Discover where money managers see opportunities in the stock market in the coming months.Read the original story w/Photo

    Nov 4, 2014 | Investor's Business Daily

    ... ET - Managers of leading mutual funds in recent months have continued to stock up on large medical stocks, such as Illumina (ILMN), Alexion Pharmaceuticals (ALXN), Celgene (CELG), Jazz Pharmaceuticals (JAZZ),Allergan (AGN) and Centene (CNC). The ...

    Comment?

  9. Apple U.S. Steel Las Vegas Sands Tesla Twitter Facebook PetrobrasRead the original story

    Oct 21, 2014 | Theflyonthewall.com

    Active equity options trading on open Active equity options trading on open according to Track Data: AAPL PBR AMZN C TWTR CVX VZ MCD GILD TXN On The Fly: Pre-market Movers UP AFTER EARNINGS: Apple , up 3%... Texas Instruments , up 2.3%... Harley Davidson , up 7%... Celanese , up 4%... United Technologies , up 1.4%. ALSO HIGHER: Neonode , up 20% after signing technology development agreement with global tier-one printer OEM... Illumina , up 10%, upgraded at Janney Capital following the company's better than expected Q3 earnings.

    Comment?

  10. ARK Investment Adds Genomics And Innovation ETFsRead the original story w/Photo

    Nov 4, 2014 | Seeking Alpha

    ... home to some familiar pharmaceuticals and biotechnology stocks. ARKG's largest holding is an almost 7.4% weight to Illumina (NASDAQ: ILMN ) and other top-10 holdings include medical devices giant Thermo Fisher Scientific (NYSE: TMO ), Novartis ...

    Comment?

  11. San Diego Stock ExchangeRead the original story w/Photo

    Nov 3, 2014 | San Diego Source

    ... at 177.85, down 0.06 percent from Friday. Declining issues beat advancers 53 to 46 and 93 issues were unchanged. Illumina Inc. (Nasdaq: ILMN) was the top dollar gainer, up $1.75 to $194.33. Auspex Pharmaceuticals Inc. (Nasdaq: ASPX) was the top ...

    Comment?

  12. Was That The Final Growth Stock Shakeout?Read the original story w/Photo

    Nov 3, 2014 | Seeking Alpha

    ... of huge volume. That October dip may have been the final selling wave to knock out the last of the weak hands. Illumina (NASDAQ: ILMN ) was a stock we were watching for a while, but it couldn't break through resistance in the low 180s for months. ...

    Comment?

  13. Rothberg Returns With Star Trek-Like Medical Device To Create Images And Cut With Sound WavesRead the original story w/Photo

    Nov 3, 2014 | Forbes.com

    ... three with the goal of starting more. Ion Torrent failed to succeed in unseating the main player in DNA sequencing, Illumina of San Diego, because its technology did not improve fast enough and because Life Technologies, which bought the company, ...

    Comment?

  14. Chip makers rebound after Microchip says sector outlook improvedRead the original story

    Oct 20, 2014 | Theflyonthewall.com

    ... HIGHER: Neonode (NEON), up 20% after signing technology development agreement with global tier-one printer OEM... Illumina (ILMN), up 10%, upgraded at Janney Capital following the company's better than expected Q3 earnings. DOWN AFTER EARNINGS: ...

    Comment?

  15. HTG Announces Completion of IVD Development and Supply Agreement With IlluminaRead the original story

    Oct 30, 2014 | Freshnews

    "We believe pairing the HTG EdgeSeq chemistry and automation platform with Illumina sequencing technology is a powerful combination for developing diagnostic panels that enables local molecular labs to adopt sequencing for routine clinical use," stated TJ Johnson, HTG CEO. "Our HTG EdgeSeq Research Use Only products that utilize Illumina sequencers have demonstrated outstanding performance in reproducibility and low sample requirement.

    Comment?

  16. Chipotle And Apple Suppliers Rise Among 5 Young GunsRead the original story w/Photo

    Oct 28, 2014 | Investor's Business Daily

    Youth has its advantages. Young companies often come out of the gate strong, and strong growth keeps them looking young.

    Comment?

  17. Illumina Price Target Raised to $215.00Read the original story

    Oct 27, 2014 | AmericanBankingNews.com

    ... stock. Stifel Nicolaus' price objective would suggest a potential upside of 13.68% from the stock's previous close. Illumina ( NASDAQ:ILMN ) opened at 189.12 on Monday. Illumina has a one year low of $91.03 and a one year high of $190.86. The stock ...

    Comment?

  18. Coca-Cola Bottling closes transaction to expand franchise territoryRead the original story

    Oct 13, 2014 | Theflyonthewall.com

    Coca-Cola sees initiatves bringing company back to LT growth goals Says doesn't see material improvement in unit case volume growth in 2015 On The Fly: Pre-market Movers UP AFTER EARNINGS: Apple , up 3%... Texas Instruments , up 2.3%... Harley Davidson , up 7%... Celanese , up 4%... United Technologies , up 1.4%. ALSO HIGHER: Neonode , up 20% after signing technology development agreement with global tier-one printer OEM... Illumina , up 10%, upgraded at Janney Capital following the company's better than expected Q3 earnings.

    Comment?

  19. Biotech, Medical Profits StrongRead the original story w/Photo

    Oct 24, 2014 | Investor's Business Daily

    (NASDAQ: CELG ) EPS climbed 24% and it raised guidance after upbeat Crohn's drug data. Shares rose 17% for the week, hitting a new high. (NASDAQ: ILMN ), maker of gene-sequencing systems, crushed views with a 71% EPS gain. Shares rose 15% for the week.

    Comment?

  20. Facebook Among 10 IBD 50 Stocks With Rising EstimatesRead the original story w/Photo

    Oct 23, 2014 | Investor's Business Daily

    But even with more than a billion users worldwide, the social networking giant wants more. CEO and founder Mark Zuckerberg stunned Chinese university students on Wednesday with a half-hour discussion in Mandarin.

    Comment?